Anti-aging Treatment
別名: 항노화 치료, 안티에이징
Anti-aging treatments are medical or cosmetic interventions intended to reduce visible or functional signs of aging; evidence quality varies widely.
What are anti-aging treatments and are cell-based ones proven?
Anti-aging treatments range from skin procedures and energy-based lifting to hormonal and cell-based approaches. Cell-based anti-aging treatments such as systemic injection of SVF or "stem cells" for wellness are investigational in most countries; the U.S. FDA has warned consumers about unapproved stem cell products. Ask for peer-reviewed evidence and regulatory status before any cell-based anti-aging treatment.
主要な事実
| 項目 | 値 | 出典 |
|---|---|---|
| FDA-approved stem cell products (US) | Only blood-forming stem cells (hematopoietic progenitor cells) from umbilical cord blood are FDA-approved in the US. They are approved only for blood-production disorders, not for anti-aging.時点 2024年4月9日 | [2]governmentConsumer Alert on Regenerative Medicine Products Including Stem Cells and ExosomesU.S. Food and Drug Administration |
| Exosome products (US) | The FDA has approved no exosome products時点 2024年4月9日 | [2]governmentConsumer Alert on Regenerative Medicine Products Including Stem Cells and ExosomesU.S. Food and Drug Administration |
| Reported risks of unapproved regenerative products | The FDA lists blindness, tumor formation, neurological events and bacterial infections, including life-threatening blood infections時点 2024年4月8日 | [3]governmentImportant Patient and Consumer Information About Regenerative Medicine TherapiesU.S. Food and Drug Administration |
| Growth hormone for aging (US legal status) | Distributing human growth hormone off-label to treat aging or age-related illness is illegal under the 1988 and 1990 amendments to the Food, Drug and Cosmetic Act (JAMA analysis, 2005)時点 2005年11月8日 | [4]newsGrowth Hormone Illegal For Off-label Anti-aging Use, Study WarnsScienceDaily (reporting Perls, Reisman & Olshansky, JAMA) |
| Evidence on growth hormone as anti-aging therapy | A systematic review (Liu et al., Annals of Internal Medicine, 2007; 18 study populations, 220 participants) found small changes in fat and lean mass and more adverse events. It concluded that growth hormone cannot be recommended as an anti-aging therapy.時点 2007年1月16日 | [5]academicThe safety and efficacy of growth hormone in the healthy elderly: a systematic reviewHarvard Medical School, Department of Population Medicine (citing Annals of Internal Medicine) |
| FDA-approved uses of dermal fillers | Approved for adults aged 22 and older for moderate-to-severe facial wrinkles and skin folds (e.g., nasolabial folds), for adding fullness to the lips, cheeks, chin and back of the hand, and for facial fat loss in people with HIV時点 2023年7月6日 | [6]governmentDermal Fillers (Soft Tissue Fillers)U.S. Food and Drug Administration |
| Injectable silicone for aesthetics | Not approved by the FDA for any aesthetic procedure. Risks include long-term pain, infection, scarring, permanent disfigurement, embolism, stroke and death.時点 2023年7月6日 | [6]governmentDermal Fillers (Soft Tissue Fillers)U.S. Food and Drug Administration |
| Most serious dermal filler risk | Accidental injection into a blood vessel, which can cause tissue death, blindness or stroke時点 2023年7月6日 | [6]governmentDermal Fillers (Soft Tissue Fillers)U.S. Food and Drug Administration |
| Korean government view on overseas stem cell programs | Korea's Ministry of Health and Welfare found that domestic programs referring patients to stem cell treatment in Japan for money or commissions may violate the Medical Service Act. Cell culture and treatment done abroad fall outside Korean jurisdiction. Experts quoted in the article said the claimed anti-aging effects of stem cell treatment have no scientific basis.時点 2026年3月9日 | [7]news[단독]복지부 "'일본에서 줄기세포 치료' 바이오기업, 불법 소지"Asia Economy (아시아경제) |
| Regulatory caution | Regulators warn about unproven stem cell products marketed for wellness or anti-aging | [1]governmentFDA Warns About Stem Cell TherapiesU.S. Food and Drug Administration |
概要
Anti-aging treatment (Korean: 항노화 치료, 안티에이징) is a broad umbrella term, not a single medical specialty, for interventions marketed to reduce visible or physiological signs of ageing. It covers cosmetic procedures (injectable fillers, neuromodulators, laser and energy-based lifting), hormones such as growth hormone or DHEA, supplements, and cell-based products such as stem cells or exosomes. Regulatory status differs by type. The US FDA approves dermal fillers only for specific uses such as facial wrinkles and has approved no exosome products. The only stem cell products it has approved are blood-forming cells from umbilical cord blood. A systematic review concluded that growth hormone cannot be recommended as an anti-aging therapy. Readers should check that a product is approved for the stated use, that the practitioner is licensed, and what published evidence exists.
検証済みプロバイダー
有料掲載は明示されます。検証は支払いと無関係です。SC301의원
SC301의원 (SC301 Clinic) is a plastic surgery clinic in Gangnam, Seoul, South Korea whose official site presents SVF (stromal vascular fraction) fat grafting for the breast and face, liposuction, lifting and cell banking as its main services.
プロバイダーを見る根拠と主張
公式な主張は提供者の声明であり、特に記載がない限りworldwikiが検証したものではありません。| 主張 | 種類 | 根拠 | 出典 |
|---|---|---|---|
| Systemic injection of SVF for anti-aging or wellness is investigational and not an approved treatment in most countries. | regulatory | 高 | FDA Warns About Stem Cell Therapies |
参考文献
独立出典比率 100% (11/11)- レベル A · governmentFDA Warns About Stem Cell Therapies — U.S. Food and Drug Administration · 閲覧日 2026年9月15日 · 根拠ページ
- レベル A · governmentConsumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes — U.S. Food and Drug Administration · 閲覧日 2026年11月12日 · 根拠ページ
- レベル A · governmentImportant Patient and Consumer Information About Regenerative Medicine Therapies — U.S. Food and Drug Administration · 閲覧日 2026年11月10日 · 根拠ページ
- レベル D · newsGrowth Hormone Illegal For Off-label Anti-aging Use, Study Warns — ScienceDaily (reporting Perls, Reisman & Olshansky, JAMA) · 閲覧日 2026年11月12日 · 根拠ページ
- レベル C · academicThe safety and efficacy of growth hormone in the healthy elderly: a systematic review — Harvard Medical School, Department of Population Medicine (citing Annals of Internal Medicine) · 閲覧日 2026年11月12日 · 根拠ページ
- レベル A · governmentDermal Fillers (Soft Tissue Fillers) — U.S. Food and Drug Administration · 閲覧日 2026年11月12日 · 根拠ページ
- レベル D · news[단독]복지부 "'일본에서 줄기세포 치료' 바이오기업, 불법 소지" — Asia Economy (아시아경제) · 閲覧日 2026年11月12日 · 根拠ページ
- レベル C · organizationAbout Stem Cells — patient resource — International Society for Stem Cell Research · 閲覧日 2026年11月12日 · 根拠ページ
- レベル B · academicSafety profile of autologous adipose-derived stromal vascular fraction in clinical use: an exhaustive literature review — Stem Cell Research & Therapy (2026) · 閲覧日 2026年11月12日 · 根拠ページ
- レベル C · organizationISSCR Guidelines for Stem Cell Research and Clinical Translation — International Society for Stem Cell Research · 閲覧日 2026年11月12日 · 根拠ページ
- レベル A · governmentStem Cell Basics — National Institutes of Health (NIH) · 閲覧日 2026年9月15日 · 根拠ページ